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Abstract
Background: Reliable exon recognition is key to the splicing of pre-mRNAs into mature mRNAs. TDP-43 is an RNA-
binding protein whose nuclear loss and cytoplasmic aggregation are a hallmark pathology in amyotrophic lateral
sclerosis and frontotemporal dementia (ALS/FTD). TDP-43 depletion causes the aberrant inclusion of cryptic exons
into a range of transcripts, but their extent, relevance to disease pathogenesis and whether they are caused by
other RNA-binding proteins implicated in ALS/FTD are unknown.
Methods: We developed an analysis pipeline to discover and quantify cryptic exon inclusion and applied it to
publicly available human and murine RNA-sequencing data.
Results: We detected widespread cryptic splicing in TDP-43 depletion datasets but almost none in another ALS/
FTD-linked protein FUS. Sequence motif and iCLIP analysis of cryptic exons demonstrated that they are bound by
TDP-43. Unlike the cryptic exons seen in hnRNP C depletion, those repressed by TDP-43 cannot be linked to
transposable elements. Cryptic exons are poorly conserved and inclusion overwhelmingly leads to nonsense-
mediated decay of the host transcript, with reduced transcript levels observed in differential expression analysis.
RNA-protein interaction data on 73 different RNA-binding proteins showed that, in addition to TDP-43, 7 specifically
bind TDP-43 linked cryptic exons. This suggests that TDP-43 competes with other splicing factors for binding to
cryptic exons and can repress cryptic exon inclusion.
Conclusions: Our quantitative analysis pipeline confirms the presence of cryptic exons during the depletion of TDP-43
but not FUS providing new insight into to RNA-processing dysfunction as a cause or consequence in ALS/FTD.
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Background
Splicing depends on the reliable recognition and subse-
quent removal of non-coding intronic sequence by the
multi-protein spliceosome complex. Boundaries that
demarcate exons from introns are first recognised by the
binding of the U1 small nuclear RNA (snRNA) to the 5′
splice site at the beginning of the intron and the U2
snRNA binding to the polypyrimidine tract and 3′ splice
site at the end of the intron. The two snRNAs then
interact with each other and the intronic sequence is re-
moved via a series of transesterification reactions [1].
During splicing, regulatory sequences in the nascent
RNAs recruit RNA-binding proteins (RBPs) to shape
mRNAs, selecting or omitting particular exons by acting
to enhance or repress splicing.
Due to the long length and reduced evolutionary
conservation of intronic sequences, pairs of 3′ and 5′
splice sites can emerge randomly to create potentially
new exons. These cryptic exons (also known as pseu-
doexons) arise due to mutations that create new splice
sites or remove the existing binding sites for splicing
repressors. These type of mutations have also been im-
plicated in a number of genetic diseases [2–5]. Inclusion
of a cryptic exon, untested by evolution, can destabilise
the transcript or radically alter the eventual protein
structure. The former can occur by the nonsense-
mediated decay (NMD) pathway, which occurs when a
transcript has a premature termination codon intro-
duced either directly by the cryptic exon or by a subse-
quent shift of reading frame [6, 7].
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Cryptic exons can also emerge from transposable
elements. One such example are Alu elements, the
predominant transposable element in primates which
are often found within introns in the antisense direction
[8]. The consensus Alu sequence consists of two arms
joined by an adenine-rich linker ending with a poly-
adenine tail. When transcribed in the antisense direction
these uridine-rich sequences can act as cryptic polypyri-
midine tracts and only a few mutations are required to
convert them into viable exons in a process termed exo-
nisation [9]. De novo mutations that lead to Alu exoni-
sation have been found in a range of diseases [3, 4, 10,
11] suggesting a need for regulation of potentially dam-
aging Alu exons. Alu exonisation is repressed by the
RNA binding protein hnRNP C, which competes with
the spliceosome component protein U2AF65, the part-
ner of the U2 snRNA, for binding cryptic 3′ splice sites
[12]. Due to the potentially negative effects of incorpor-
ation of new exons, aberrant recognition of cryptic
exons needs to be repressed.
TDP-43 is an RNA-binding protein encoded by the
TARDBP gene. Loss of TDP-43 from the nucleus accom-
panied by TDP-43 positive inclusions in the cytoplasm
of cortical and spinal cord neurons is the hallmark path-
ology of amyotrophic lateral sclerosis (ALS) as well as
the majority of cases of frontotemporal dementia (FTD)
[13]. In addition, missense mutations in TARDBP can
cause familial ALS [14]. These findings point to a central
role of TDP-43 in the aetiology of ALS and FTD.
Rare ALS-causing mutations have been found in an-
other RNA-binding protein, FUS [15] further raising the
possibility that the impairment of RNA processing is a
central cause of ALS. TDP-43 was first shown to repress
the inclusion of exon 9 in the CFTR gene by binding to
long UG-rich sequences [16] and subsequently shown to
act as both a splicing enhancer and repressor [17–19].
TDP-43 and FUS have both been shown to bind a set of
overlapping RNA targets [20]. Transcriptome-wide stud-
ies of the effects of TDP-43 depletion, overexpression or
mutation have demonstrated widespread changes in
gene expression and splicing [21–24]. Of particular
interest are long intron containing genes, which are dra-
matically downregulated during both TDP-43 and FUS
depletion [20, 23].
Recently, Ling and colleagues observed the inclusion
of cryptic exons when TDP-43 was depleted in HeLa or
mouse embryonic stem cells [25]. These cryptic exons
were shown to originate from poorly evolutionarily con-
served sequence and shared no positions between the
two species. These findings raise the possibility that im-
paired exon recognition contributes to TDP-43’s role in
ALS aetiology. We therefore aimed to replicate and
expand the findings of Ling and colleagues. Firstly, we
undertook a quantitative genome-wide analysis of cryptic
exon patterns, defining objective criteria that take advan-
tage of biological replicates when available. Secondly, we
applied this computational strategy to seven datasets (four
human and three murine models) to systematically quan-
tify cryptic RNA alterations associated with depletion of
TDP-43. In addition we also investigated FUS in order to
determine whether modulation of cryptic splicing was a
common feature of RBPs implicated in ALS. We also
analysed hnRNP C, as it had been previously shown to
repress cryptic exons. Lastly, we used independent
protein-RNA interaction datasets, conservation data,
repeat element annotation and splice site scoring to inves-
tigate the potential mechanisms linking TDP-43 depletion
with the cryptic exon phenomenon.
Methods
Data preparation
Table 1 lists all the public data used in this study. For all
RNA-seq data we first performed adapter and quality
trimming (Phred score > 20) with Trim Galore (0.4.1) on
the FASTQ files before aligning to either the human
(hg38) or mouse (mm10) reference genome with STAR
(2.4.2a) [26]. The resulting BAM file was sorted and
PCR duplicate marked with NovoSort (1.03.09). Proc-
essed iCLIP peaks data was downloaded from the
iCOUNT server (http://icount.biolab.si/). Both the
human and mouse TDP-43 iCLIP data have been previ-
ously published [27, 28].
Processed eCLIP data (previously described by [29])
was downloaded from the ENCODE project. The nar-
rowPeaks bed format was used with the first nucleotide
of the cluster defined as the peak. Peak coordinates from
iCLIP and eCLIP were converted to the hg38 and mm10
builds using the LiftOver tool from UCSC.
Cryptic splicing definition
Splicing aware alignment software such as STAR cut
short reads that originate from a spliced transcript and
align the pieces separately, marking the distance between
them as a splice junction. Splice junctions can be used
to reaffirm known splicing patterns or infer novel spli-
cing. We define cryptic splicing as the emergence or
relative increase in splice junctions that splice from
known splice sites to unannotated positions within in-
trons. This increase correlates with the depletion of a
particular RNA binding protein. Different repositories
have different levels of proof for annotating exons but
we define an annotated exon as one listed in the
Ensembl list of transcripts (release 82).
Cryptic splicing discovery with the CryptEx pipeline
Due to the diversity in the quality of published RNA-seq
data, the cryptic splicing discovery pipeline was designed
to be used on any RNA-seq library, whether single or
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paired end, stranded or unstranded, total RNA or
polyA-selected RNA. However, when high quality RNA-
seq data is available (paired end reads >100bp sequenced
with >30M reads per sample), we instead suggest using
one of the several recently released tools that can iden-
tify and classify unannotated splice junctions such as
JunctionSeq [30], Leafcutter [31], MAJIQ [32] or SGSeq
[33].
The inherent flexibility of our pipeline results in a
large number of false positive hits which have to be ag-
gressively filtered downstream. The initial cryptic exon
discovery pipeline was written in Bash, using SAMTools
(version 1.2) [34] and BEDTools (version 2.25.0) [35].
The statistical testing for differential cryptic exon usage
was carried out using the well-known DEXSeq frame-
work [36]. All code for downstream processing and
filtering of cryptic hits was written in the R language
(version 3.1.1) using the Biostrings, data.table, DEXSeq,
dplyr, GenomicRanges, ggplot2, gridExtra, optparse, plyr,
stringr, and tidyr packages. All the code for reproducing
this paper is available in a GitHub repository [37].
In order to discover all possible splice junctions that
travel into the intron we first extracted all spliced reads
from each aligned bam file using SAMTools, filtering
out any secondary alignments. To extract only the
spliced reads that overlap an annotated exon we then
performed an intersection in BEDTools with a flattened
list of exons, created using the dexseq prepare annota-
tion.py Python script included with the DEXSeq package
[36]. An inverse intersection was then performed with
the same exon list to retain only the spliced reads which
do not bridge two annotated exons. The intronic map-
ping sections of each read were split off from the rest
and retained. In each dataset all intronic mapping
spliced reads from each sample were grouped together
irrespective of condition. Split reads that were within
500bp of each other were merged into larger intervals,
hereby referred to as tags. This ideally captures both the
upstream and downstream splice junction to a central
cryptic cassette exon. To keep only the tags that are spli-
cing within the gene body another intersection was per-
formed with a list of introns. This was generated from
the same flattened exon file by an R script written by
Devon Ryan [38]. The tags were then incorporated into
the flattened list of exons. The reads that overlap anno-
tated exons and tags were counted using HTSeq [39] on
the default settings, ignoring PCR duplicate reads. The
read counts were used to calculate differential usage of
each exon with DEXSeq.
All the cryptic tags with an adjusted P-value (false dis-
covery rate) < 5% and a | log2(fold change)| > 0.6 were
extracted from the DEXSeq results table (see Additional
file 1: Figure S1). The splice junctions from the align-
ment of each sample were used to work out the coordi-
nates of the canonical junction that spans the intron
within which the cryptic tag is or isn’t spliced in control
samples. Using splice junctions from the depletion con-
dition samples, the upstream and downstream junctions
Table 1 List of accessions. For the ENCODE RNA-seq libraries, the control and target depletion samples are listed under separate
accessions
Assay Accession Code Downloaded from Target Cell-Tissue Pubmed ID
RNA-seq PRJNA282887 ncbi.nlm.nih.gov/sra TDP-43 Mouse ES 26250685
RNA-seq PRJNA282692 ncbi.nlm.nih.gov/sra TDP-43 Human Hela 26250685
RNA seq PRJNA127211 ncbi.nlm.nih.gov/sra TDP-43 Mouse ES 20660762
RNA-seq PRJNA141971 ncbi.nlm.nih.gov/sra TDP-43 Mouse adult brain 21358643
RNA-seq ENCSR129RWD encodeproject.com control K562 mRNA NA
RNA-seq ENCSR134JRE encodeproject.com TDP-43 K562 mRNA NA
RNA-seq ENCSR372DZW encodeproject.com control K562 total RNA NA
RNA seq ENCSR455TNF encodeproject.com TDP-43 K562 total RNA NA
RNA-seq PRJNA174534 ncbi.nlm.nih.gov/sra FUS Mouse adult brain 23023293
RNA-seq ENCSR084SCN encodeproject.com control K562 mRNA NA
RNA-seq ENCSR32500M encodeproject.com FUS K562 mRNA NA
RNA-seq PRJEB3048 ncbi.nlm.nih.gov/sra hnRNP C HeLa 23374342
iCLIP 20100222_LUjt3 icount.biolab.si TDP-43 Mouse embryonic brain 1 22934129
iCLIP 20091102_LUjt5 icount.biolab.si TDP-43 Mouse embryonic brain 2 22934129
iCLIP 20100222_LUjt3 icount.biolab.si TDP-43 Human neural stem cells 21358640
iCLIP 20101125_LUjt8 icount.biolab.si TDP-43 Human SH-SY5Y 1 21358640
iCLIP 20091102_LUjt5 icount.biolab.si TDP-43 Human SH-SY5Y 2 21358640
eCLIP Multiple encodeproject.com Multiple HepG2/K562 NA
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that connect the adjacent annotated exons to the cryptic
tag were re-discovered and quantified. Any cryptic ex-
ample that did not have at least one upstream or down-
stream junction per sample or had fewer than ten
canonical splice junctions was removed. These junctions
were used to calculate per-condition mean Percent Spliced
In (PSI) values which are a ratio of cryptic splicing over
the sum of cryptic and canonical splicing [40]. As a num-
ber of cryptic splicing events are present at a low level in
control samples, ΔPSI values were created for both up-
stream and downstream splicing for each tag. This is the
difference in PSI between the depletion samples and the
control samples. Any cryptic tag that had either an up-
stream or downstream ΔPSI < 5% was removed.
iCLIP/eCLIP enrichment
The coordinates of each cryptic tag were flanked by 100
base pairs on either side to capture binding around the
putative splice sites. In order to compare the overlap be-
tween cryptic exons and RNA-protein binding peaks,
two sets of null exons were created for comparison,
which maintain the same length as their corresponding
cryptic exon but sample either the intronic sequence
outside of the flanked exon or that of the adjacent
introns within the same gene if available. Overlaps
between exons and iCLIP and eCLIP peaks were calcu-
lated using BedTools.
Motif enrichment analysis
FASTA sequence was generated for the cryptic exons
flanked by 100 nucleotides either side and submitted to
the MEME web tool [41] under the default settings. The
analysis was repeated using the HOMER algorithm [42]
on RNA mode. Motifs were created using WebLogo
[43]. Frequencies of the 16 possible dinucleotides were
compared between flanked cryptic exon sequences with
adjacent intron sequences from the same gene.
Transposable element enrichment
Lists of transposable elements in human and mouse
(hg38 and mm10 respectively) were previously generated
by the RepeatMasker tool [44] and were downloaded
from UCSC. Overlap between different transposable
elements and the cryptic exons was calculated in each
orientation using BedTools.
Conservation analysis
PhyloP compares the sequence alignments of multiple
species to produce per base conservation scores [45].
Average conservation score per cryptic tag was calcu-
lated using bigWigSummary (UCSC) for both human
and mouse data. The lists of splice junctions created by
STAR when aligning each sample were used to identify
the coordinates of the exons adjacent to the cryptic
exon. The randomly sampled intronic sequence from the
cryptic-containing intron was used as a negative control.
Differential expression
For each sample the number of reads overlapping each
gene were counted using HTSeq using the same
Ensembl gene models as before. Differentially expressed
genes were identified using DESeq2 [46] at a false
discovery rate of 10%.
Protein prediction analysis
Any cryptic exon which did not fall within the coding
sequence of a transcript was omitted. Splice junctions
generated by STAR were used to determine the up-
stream and downstream exons adjacent to each cryptic
exon. Only cryptic exons that had both upstream and
downstream splice junctions (cassette exons) were kept.
The upstream and downstream exons were matched to
their corresponding annotated exon in the Ensembl
transcript file for each species to assign the correct
reading frame for translation. Nucleotide sequences for
transcripts either including or excluding the central
cryptic exon were created and translated in silico using
the R Biostrings package. Premature termination codons
(PTCs) were identified from the translated sequence and
defined as escaping nonsense mediated decay (NMD) if
they occurred within 50 nucleotides of the downstream
exon-exon junction. Frameshifts were identified by com-
paring the sequence of the downstream exon with and
without the central cryptic exon. A null distribution of
PTC-containing or frame shifted transcripts was created
by generating central exons from random nucleotide
sequence, keeping the length distribution the same. For
each species this was repeated 100 times.
Splice junction scoring
The strength of 5′ and 3′ splice sites was calculated for
the human cryptic exons using maxEnt [47]. Higher
scores indicate the increased log odds of a given splice
site being a true splice site. The 5′ splice site is defined
as the last 3 nucleotides of the upstream exon flanked by
6 intronic nucleotides, of which the first two are invari-
ably GU. The 3′ splice site is defined as the last 20 in-
tronic nucleotides of which the final two are invariably
AG, flanked by the first 3 nucleotides of the downstream
exon. The splice sites of annotated exons were used as a
positive control. Randomly generated sequence with in-
variant AG or GT was used as a negative control. Paired
t-tests were carried out to test the direction of change
between the cryptic and annotated splice sites for each
class of cryptic exon.
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Results
Depletion of TDP-43 but not FUS results in cryptic exons
We compared the involvement of two ALS-linked
RNA-binding proteins in cryptic splicing: TDP-43 and
FUS. We analyzed publicly available TDP-43 depletion
RNA-Seq datasets (three human, three murine, data-
sets 1–6 in Table 2), FUS depletion RNA-Seq datasets
(1 human, 1 murine, datasets 7–8 in Table 2) and as
a positive control a human hnRNP C depletion data-
set for which cryptic exons have previously been
reported (dataset 9 in Table 2). While these datasets
differ in library preparation method, read depth and
length, and protein depletion method (Table 2), the
FUS datasets match the TDP-43 datasets in cell type,
depletion method sequencing depth and lab of origin
(Table 2), as do the TDP-43 and FUS depletion data
created by the ENCODE consortium. Using these
datasets, we took a genome-wide approach to de-
scribe the pattern of unannotated splicing in human
and mouse that we call CryptEx. The first step in-
volves identifying novel splice junctions between an-
notated exons and unannotated intronic regions.
These reads were clustered to create putative cryptic
exons. Making use of biological replicate samples we
compared the abundance of reads covering the cryptic
region relative to the rest of the annotated exons of
the surrounding gene. Differential usage of each cryp-
tic region was tested between depletion and control
samples. Results were omitted if they fell outside of a
strict 5% false discovery rate.
In order to further refine our cryptic exon detection
algorithm, we then measured the amount of splicing to
and from each region and used this information to filter
and classify cryptic splicing events into three categories
of cryptic exon: (i) cassette-like, where novel 3′ and 5′
splice sites are recognised, which forms a completely
new exon; (ii) 5′ extension, where a novel 3′ splice site
is recognised and an existing exon is extended upstream
of its annotated start and (iii) 3′ extension, where a
novel 5′ splice site is recognised and an exon is ex-
tended downstream of its annotated end (Fig. 1a). Note
that our approach does not consider fully retained in-
trons, but several other methods have been designed for
this purpose [48–51].
Figure 1b lists the counts of both pre-classification
cryptic regions (“unfiltered output”) and the post-
classification cryptic exons. Comparing the two human
ENCODE K562 cell line TDP-43 depletion datasets (3-
4), the poly-A selected mRNA-Seq dataset yielded far
more splicing events than the total RNA dataset, pre-
sumably due to polyA selection leading to a higher
coverage of mature spliced mRNA species. In total 95
human cryptic exons were discovered and classified,
with the majority only detected in the mRNA-seq data-
set. 11 cryptic splicing events were shared between data-
sets 3 and 4 (Fig. 1c). Of the 26 human cryptic exons
reported by Ling, 12 were seen in at least one of the two
datasets 3 and 4.
Both mouse datasets differ in both cell type (adult stri-
atum in dataset 5 vs embryonic stem (ES) cell in dataset
6) and read depth (35-60M in dataset 5 vs 2-10M in
dataset 6). 52 cryptic exons were identified in total, with
46 detected in the adult striatum and 15 in ES cells, with
6 exons observed in both. Of the 46 cryptic splicing
events identified in murine samples by Ling et al, 13
were detected in at least one of datasets 5 and 6. Side by
side visual inspection (Additional file 2: Figure S2 and
Additional file 3: Figure S3) suggests that differences in
library preparation and read depth are behind the low
concordance rates in both human and mouse, as cryptic
exons detected in the higher depth dataset (K562 mRNA
and mouse adult brain) can be observed by eye in the
lower depth dataset (K562 total RNA and mouse ES
cell). These exons currently fail to be detected by the
CryptEx algorithm.
No cryptic splicing events were shared between human
and mouse as previously reported [25]. Note that to re-
port overlap with Ling and colleagues (datasets 1 and 2),
Table 2 All RNA-sequencing data used in this study
Species Cell type Protein Depletion Library type Read type Depth Citation
1 Human HeLa TDP-43 siRNA mRNA l00bp PE 97-116M Ling, 2015 [25]
2 Mouse ES TDP-43 Knockout mRNA l00bp PE 70-75M Ling, 2015 [25]
3 Human K562 TDP-43 shRNA Total RNA l00bp PE 55-62M ENCODE
4 Human K562 TDP-43 shRNA mRNA l00bp PE 25-29M ENCODE
5 Mouse Adult brain TDP-43 ASO mRNA 75bp SE 35-60M Polymenidou, 2011 [23]
6 Mouse ES TDP-43 Knockout mRNA 40bp SE 2-11M Chiang, 2010 [21]
7 Human K562 FUS shRNA mRNA l00bp SE 12-21M ENCODE
8 Mouse Adult brain FUS ASO mRNA 72bp SE 20-60M Lagier-Tourenne, 2012 [20]
9 Human HeLa hnRNP C siRNA mRNA 72bp SE 26-28M Zarnack, 2013 [12]
For single end sequencing, depth is measured in millions of mapped reads whereas paired end sequencing depth is measured in millions of mapped fragments
ES leukaemia cell line. siRNA small interfering RNA, shRNA short hairpin RNA, ASO antisense oligonucleotide, PE paired end sequencing, SE single end sequencing
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the raw data was unsuitable for our cryptic exon discov-
ery pipeline due to a lack of biological replicate samples.
Instead the sequence data was aligned and the splice
junctions generated by the aligner were used to classify
previously reported cryptic exons.
In contrast, while a large number of novel splicing
events were observed in the FUS depletion datasets, our
algorithm only classified 3 in mouse and 1 in human as
cryptic exons. FUS depletion was not observed to produce
any cassette-like cryptic exons in either species. Additional
file 1: Figure S1 visualises the full unclassified output of
the pipeline and illustrates the diversity of splicing alter-
ations that occur upon RBP depletion. Additional file 2:
Figure S2 and Additional file 3: Figure S3 comprise of
screenshots of every reported cryptic exon from the IGV
browser in mouse and human respectively. Additional file 4:
Tables S1 and S2 (ST1/ST2) list the coordinates of each
cryptic exon along with the results of each experiment.
To verify that the cryptic exons were not included under
normal conditions, we looked for evidence of the 52 total
mouse cryptic exons in a set of 9 mouse tissues previously
published in [52]. For the 95 total human cryptic exons
we looked for evidence of inclusion in 49 normal human
tissues collected by the GTEx project [53]. For each cryp-
tic exon we looked for junctions that splice to and from
the cryptic exon and divided by the counts of a junction
that spans the length of it, to produce a ratio of cryptic
exon inclusion. Only 4 mouse and 3 human cryptic exons
showed any evidence of being included at all in normal
tissues, albeit at low levels and with very high variability
(Additional file 5: Tables S5 and S6). This suggests that
the cryptic exons we discovered are generally not included
Fig. 1 Cryptic splicing discovered by the CryptEx pipeline. a Schematic of the three classes of cryptic exon. Black boxes represent annotated
exons and red boxes represent a cryptic exon. Grey lines represent the spliced intron. b Tally of the three classes of cryptic exon discovered by the
CryptEx pipeline across the nine datasets. “Unfiltered output” refers to the number of differentially used cryptic splicing events at a false discovery
rate (FDR) < 5% before undergoing cryptic exon classification. Counts from Ling et al’s data are taken from the paper itself. c Venn diagrams
showing the overlap between the six TDP-43 depletion datasets
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in normal tissues and that they can only be seen during
the depletion of TDP-43.
Cryptic exons are enriched in TDP-43 binding motifs and
iCLIP peaks
For the remainder of our study, cryptic exons were
grouped into unions of all cassette-like exons and exten-
sion events discovered in human and mouse, totalling 95
human and 52 murine cryptic exons. We then explored
whether TDP-43 binding could explain the observed
splicing changes in RNA-Seq data, as observed by Ling
and colleagues. We took two complementary and
genome-wide approaches: (i) searching for enriched mo-
tifs in the RNA sequence including and surrounding the
cryptic exons and (ii) correlating the positions of cryptic
exons with TDP-43 protein-RNA interaction data.
TDP-43 can repress or enhance the inclusion of a given
exon by either binding within or adjacent to the exonic se-
quence [27]. Hence for our motif search, we flanked cryp-
tic exon sequences by 100 nucleotides on either side. UG-
rich motifs were found to be enriched in both mouse and
human cryptic exons using two different algorithms:
MEME (Fig. 2a) and HOMER (Additional file 6: Figure
S4). Of the 52 mouse cryptic exons 29 had a run of UG up
to 40 nucleotides in length. Similarly, human cryptic
exons were enriched in a UG motif but not in a continu-
ous manner. By comparing the frequencies of 16 possible
dinucleotides between the flanked cryptic exon sequence
and the sequence of the adjacent intron either up or
downstream of the cryptic-containing intron we were able
to resolve the enrichment of UG dinucleotides (Fig. 2b).
UG and GU were enriched in flanked cryptic exon se-
quence in both human (fold change GU= 1.53; UG = 1.48;
P < 10−50; proportion test) and mouse (fold change GU=
2.14; UG = 1.85; P < 10−50; proportion test).
Individual nucleotide resolution UV crosslinking
followed by immunoprecipitation (iCLIP) allows for pre-
cise nucleotide-resolution observation of which RNA spe-
cies interact with a particular RNA-binding protein [12,
54]. We downloaded all publicly available TDP-43 iCLIP
data from the iCount repository (http://icount.biolab.si/).
We then intersected each set of iCLIP peaks with our
cryptic exons, surrounded by 100 base pairs of flanking se-
quence either side. The proportion of overlapping cryptic
exons was compared to the proportion of overlap between
iCLIP peaks and two classes of null exon; the first created
from the surrounding intronic sequence outside of each
flanked cryptic and the second from an adjacent intron
(Fig. 2c). If TDP-43 binding was uniform throughout an
intron or gene then we would expect to see similar pro-
portions of overlap in each. However, both species show
an enrichment in TDP-43 binding peaks specific to the
cryptic exons in every iCLIP dataset used, with as much as
25% of human cryptic exons and 50% of mouse cryptic
exons overlapping at least one iCLIP peak each (Fig. 2d;
both species P < 10−16; proportion test).
Cryptic exons are marginally enriched in transposable
elements
Motivated by previous findings of cryptic exons associ-
ated with hnRNP C depletion and caused by exonisation
of antisense Alu elements [12, 55], we investigated
whether TDP-43 induced cryptic exons preferentially
overlap specific families of transposable elements and/or
class of repetitive sequences. Transposable/repeat elem-
ent annotations were obtained using the RepeatMasker
software and these features were split by family and
orientation. Although Alu elements are a subfamily
within the primate SINE element family, we included
them separately given the prior hnRNP C result. As
transposable elements are abundant in the genome, the
number of overlapping exons was compared as before to
the overlap in the whole intron and adjacent introns.
The mouse cryptic exons show a modest enrichment
in antisense SINE elements in and around the cryptic
exons when compared to the rest of the surrounding in-
tron. However the elements are also common in adja-
cent introns and so are not enriched for this comparison
(Fig. 3a). The antisense SINE elements are mainly from
the B2 family (Additional file 7: Table S3) which in the
antisense direction is rich in stretches of UG dinucleo-
tides (Additional file 7: Figure S5). Mouse cryptic exons
are also enriched in repeat elements annotated as “low
complexity” or “simple repeat”, which are also mostly
UG dinucleotide repeats, labelled as such or as AC re-
peats antisense to the direction of transcription. The hu-
man cryptic exons only show a small enrichment
in”simple repeat” elements (Fig. 3b), most of which con-
tain sense UG or antisense AC repeats (Additional file 7:
Table S4). This contrasts with hnRNP C depletion,
which shows a striking enrichment of antisense SINE
elements of which all are of the Alu type (P < 10−16; pro-
portion test), a result consistent with previous analyses
of dataset 9 [12]. Altogether, these results are in line
with findings from the motif analysis, that cryptic exons
are enriched in TDP-43 binding motifs but not due to
the large - scale enrichment in transposable elements.
Cryptic exons are poorly conserved and their inclusion
acts to destabilise their host transcript
We then quantified the extent of evolutionary conserva-
tion of cryptic exons using the multiple species align-
ment conservation scores generated by PhyloP. We
calculated mean conservation scores per exon for the
cryptic exons and compared them to scores from both
the annotated exons and randomly sampled intronic se-
quences from the same genes. We found no difference
between cryptic exons and matched intronic sequences
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Fig. 2 Evidence of TDP-43 binding cryptic exons. a Results of MEME motif search. Only the motif with the greatest enrichment compared to background
sequence is presented. b Dinucleotide enrichment in the flanked cryptic exons compared to adjacent introns. c Schematic of iCLIP peak enrichment test. For
illustration a cassette-like cryptic exon (green box) is shown between two annotated exons (black boxes) separated by intronic sequence (black lines). The pro-
portion of the group of cryptic exons flanked either side by 100 nucleotides (orange) that overlap at least one iCLIP peak is compared to the proportion of
overlaps in a group of length matched sequences from either the surrounding intron (yellow) or an adjacent intron (blue) each randomly sampled 100 times
per gene. d iCLIP peak overlap enrichment for the 95 human cryptic exons found in either K562 cell TDP-43 depletion dataset and the 52 cryptic exons found
in either mouse TDP-43 depletion dataset. Error bars denote 95% confidence intervals of the binomial distribution. ∗P< 0.05, ∗∗P< 0.001, ∗∗∗P< 10−16. All
P-values adjusted for multiple testing by Bonferroni method
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(Fig. 4a), and a much lower conservation level than adja-
cent annotated exons.
We also investigated the consequences of inclusion of
cryptic exons on translation of the transcript. The inclu-
sion of a premature termination codon (PTC) into a
transcript could lead to either mRNA degradation by the
nonsense-mediated decay (NMD) pathway. Alternatively,
if the PTC falls within 50 nucleotides upstream of an
exon-exon junction then NMD can be evaded, leading
to the production of a truncated protein [7]. These two
outcomes are compounded by the possibility of a cryptic
exon shifting the reading frame of the downstream exon,
leading either to more PTCs or the creation of a benign
transcript of a different function. This gives cryptic exon
inclusion six functional outcomes that can destabilise
either the RNA or the downstream protein. We tested
for all these outcomes by translating the predicted
transcripts in silico. In this analysis we only considered
the”cassette-like” cryptic exons that had both upstream
and downstream splice junctions. Of the 31 human cryp-
tic exons tested, 21 (67%) are predicted to destabilise
their host transcript through the NMD pathway (Fig. 4b).
Five cryptic exons are predicted to impart new function-
ality whereas five others are predicted to contain prema-
ture stop codons but evade NMD, creating truncated
proteins upon translation. However, comparing these re-
sults to randomly generated sequence of the same length
demonstrates that this distribution of outcomes can
occur purely by chance. The 23 mouse cryptic exons
tested behave similarly, with four cryptic exons creating
functional proteins, one creating a new downstream pro-
tein, six leading to protein truncation and 12 being de-
graded by NMD (Fig. 4b). The random sequences were
similarly distributed. Together this suggests that the
Fig. 3 Cryptic exons in transposable elements Overlap between different families of repetitive element with lists of exons, separated by orientation. a Mouse
TDP-43 depletion. b Human TDP-43 depletion. c Human hnRNP C depletion. The proportion of the cryptic exons that contain a particular element are shown
in orange. Length - matched random samples from the surrounding intron (yellow) and adjacent introns (blue) are used as controls. LINE: Long Interspersed
Nuclear Element; SINE: Short Interspersed Nuclear Element. ∗ : P< 0.05, ∗∗ : P< 0.001, ∗∗∗ : P<10−16 . All P-values corrected for multiple testing with
Bonferroni method
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cryptic exons are not enriched in particular sequence
features and upon inclusion behave like randomly
chosen sequences. This disruption of multiple mRNA
species may have an effect at the protein level and ex-
plain the toxicity seen in response to TDP-43 depletion.
Cryptic exon containing genes are downregulated
We then investigated, in datasets 3-6, whether genes
containing cryptic exons showed a specific pattern of
altered expression. We calculated the proportion of
the cryptic exon containing genes in each dataset that
were differentially expressed at a FDR of 10%. We
compared this with the proportion of differential
expression of all genes with an expression level at or
greater than the lowest expressed cryptic exon found in
that dataset. Figure 5a shows the number of differentially
expressed genes in each dataset as a proportion of the
total, separated by direction. In all four TDP-43 depletion
datasets, the cryptic exon containing genes as a group
are more likely to be significantly downregulated
compared to the genome-wide proportion (P < 0.001;
hypergeometric test).
Furthermore, we performed the same analysis for
each dataset with the cryptic exon containing genes
that were only found in the other dataset of the same
species (Fig. 5b). Surprisingly, in the mouse ES cell
dataset 6 there was an enrichment of downregulated
genes that contain cryptic exons only detectable in
the mouse adult brain dataset 5 (P < 0.001; hypergeo-
metric test). Visual inspection of these 10 introns in
the mouse ES cell data (Additional file 2: Figure S2)
suggests that seven of them may harbour cryptic
exons in the ES cell data that are currently undetect-
able by the CryptEx algorithm.
Human cryptic exons are driven by the recognition of
strong splice sites that are normally repressed
Whereas cassette-like cryptic exons appear as separate
exons distinct from their surrounding exons, extension
events must rely on a switch from a canonical splice site
Fig. 4 Conservation and premature termination codon analysis. a Per exon average PhyloP conservation scores in cryptic exons, adjacent exons
within the same set of genes (when available) and randomly sampled sequences from the cryptic containing intron. Box plots show first quartile,
median and third quartile with the notches representing the 95% confidence interval of the median. Whiskers represent the minimum and
maximum values that fall within 1.5 times the interquartile range. b The functional impact of cryptic exon inclusion on the host transcripts in
human and mouse. Colours indicate the category of prediction and box size indicates the proportion of the total group of exons in each
category. Categories from top to bottom: Frame shifted (red); Frame shifted and at least one premature termination codon (PTC) included
(orange); PTC included only (yellow); Frame shifted but the resulting PTC falls within 50bp of the exon-exon junction, creating a truncated protein
of novel sequence (light blue); PTC falls within 50bp of the exon-exon junction, creating a truncated protein (dark blue); Frame shift without any
PTCs to create a protein of novel sequence (light green); Cryptic exon inclusion does not frame shift nor introduces a PTC, behaving as a benign
cassette exon (dark green). For each species there is a corresponding set of predictions calculated from random sequences with matching lengths
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to a newly accessible splice site. We hypothesised that
these extension events result from competition between
two splice sites upon TDP-43 depletion. This would re-
quire the sequence of and around the cryptic splice site
to be similarly recognisable to the spliceosome. Using
the MaxEnt statistical model [47] to score splice sites by
comparing their DNA sequences with constitutive ob-
served canonical sequences, we scored the 5′ and 3′
splice sites of our cryptic exons and compared them
with the scores of the surrounding canonical splice sites.
The model compares splice sites from annotated exons
with so-called decoy splice sites that retain the consen-
sus AG/GT at the 3′ or 5′ splice site respectively. There-
fore we also scored randomly generated sequences,
which retained the consensus AG/GT positions. Figure 6
shows the scores for both the 3′ and 5′ splice sites for
each class of human cryptic exons. Although the ca-
nonical splice sites were on average stronger than
their corresponding cryptic splice site (P < 0.05; paired
t-test), the majority had scores far greater than those
from random sequence, suggesting that they are able
function as real, albeit weaker, splice sites when TDP-
43 is depleted.
Cryptic exons are bound by other RNA - binding proteins
Proteomic studies have demonstrated that TDP-43 inter-
acts with a number of RNA-binding proteins (RBPs), in-
cluding multiple members of the heterologously
expressed ribonucleoprotein (hnRNP) family and other
splicing factors [56–58]. The splicing of specific anno-
tated exons has been shown to depend on the inter-
action of TDP-43 with multiple splicing factors [59]. We
hypothesised that some cryptic exons may be included
indirectly through a loss of TDP-43’s interactions with
different RBPs. Van Nostrand and colleagues have per-
formed eCLIP, a higher throughput modification of the
iCLIP protocol, on 73 different RBPs including TDP-43
and FUS [29]. The experiments were carried out in two
human cell lines (K562 and HepG2) with 29 of the RBPs
being tested in both cell lines. We performed the same
overlap analysis between our human cryptic exons and
each set of eCLIP peaks, using the same two sets of
control sequences as before. Each eCLIP experiment was
performed in duplicate. This gives each RBP four
possible enrichment results using a proportion test. For
each RBP, the highest P-value from the four tests was re-
ported and corrected for multiple testing using a strict
Fig. 5 Differential expression of cryptic exon genes. a Significantly differentially expressed genes between TDP-43 depletion and control samples
(false discovery rate = 10%) in datasets 3-6. Comparisons were made between all genes tested with an expression level at or greater than the
lowest expressed cryptic exon (“all genes”) and the genes where cryptic exons were discovered (“cryptic exon genes”) with each group divided
by direction of change. b As above but for cryptic exon genes from the other dataset of the same species. Error bars show 95% confidence
intervals for each proportion. ∗ : P < 0.05, ∗∗ : P < 0.001. All P-values adjusted by Bonferroni correction
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Bonferroni approach. Only proteins with a resulting P <
0.05 are reported. Unsurprisingly TDP-43 had the high-
est number of overlapping exons (P < 10−22; proportion
test), followed by U2AF65, TIA1, SRSF7, U2AF35, PPIG,
SRSF1 and IGF2BP1. Figure 7a shows the overlap be-
tween the different RBPs and the human cryptic exons.
Figure 7b shows the overlap between each gene (col-
umns) against each RBP (rows). Hierarchical clustering
was performed on the RBPs. The three largest clusters
consist of TDP-43 alone, the U2 snRNP binding proteins
U2AF35 and U2AF65, and a third cluster containing the
other proteins.
Discussion
We have designed an analytical strategy to identify cryp-
tic splicing that takes advantage of biological replicates
in RNA sequencing data. We have applied this tool to a
set of human and murine TDP-43 depletion datasets, as
well as datasets that deplete hnRNP C or FUS. Our
results are consistent with the previous findings that
depletion of TDP-43 or hnRNP C leads to the inclusion
of novel cryptic exons in both human and mouse, albeit
with hnRNP C depletion leading to a far greater number
of events than TDP-43. Although FUS undoubtedly
plays an important role in splicing and mRNA stability
and shares a number of targets with TDP-43 [20], the
low number of cryptic exons observed due to FUS de-
pletion suggests that it does not play a major role in
cryptic splicing and is a key point of differentiation with
TDP-43. This is despite the FUS and TDP-43 data ana-
lysed being produced under the same conditions for
both mouse and human.
Further examination of TDP-43 linked exons suggests
they tend to possess the necessary UG-rich sequence el-
ements to be bound by TDP-43 and using iCLIP data we
observed that a subset of the cryptic exons are bound by
TDP-43 in vivo. We went on to investigate the origins of
these TDP-43 bound cryptic exons, as has been done for
the targets of hnRNP C. We observed that unlike
hnRNP C linked cryptic exons, which invariably origin-
ate from antisense Alu elements, TDP-43 linked cryptic
exons do not originate from any single family of trans-
posable element. Furthermore their sequences show very
low species conservation, akin to random intronic se-
quence, but remarkably they contain splice sites very
close in strength to those of their adjacent annotated
exons. Our differential expression analysis suggests that
the bulk of cryptic exon containing genes are
Fig. 6 Scoring cryptic splice sites against canonical splice sites. Cassette-like cryptic exons have 5′ and 3′ splice sites that are recognised by the spliceosome
under TDP-43 depletion. 5′ and 3′ splice site scores are plotted separately. Cryptic splice sites are shown in red, canonical splice sites are shown in blue.
Random sequences with AG or GT consensus are plotted in grey. Cryptic extensions are the result of a cryptic splice site competing with the canonical
splice site. 5′ extensions result from cryptic 3′ splice sites whereas 3′ extensions result from cryptic 5′ splice sites. Box plots show first quartile, median and
third quartile with the notches representing the 95% confidence interval of the median. Whiskers represent the minimum and maximum values that fall
within 1.5 times the interquartile range. Outliers are plotted as black dots. Cryptic splice sites are compared to canonical splice sites with paired t-tests.
∗ : P< 0.05, ∗∗ : P< 0.001
Humphrey et al. BMC Medical Genomics  (2017) 10:38 Page 12 of 17
Fig. 7 (See legend on next page.)
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significantly downregulated upon TDP-43 depletion. We
hypothesize that while some cassette-like cryptic exons
will create functional or truncated proteins, most will
lead to premature stop codons and nonsense-mediated
decay of the inclusion transcript. The large number of
exon extensions discovered by CryptEx may similarly
lead to frameshifting and nonsense-mediated decay upon
inclusion but may alternatively be sequestered in the nu-
cleus and degraded by the mRNA surveillance pathway,
as has been observed for retained introns [60]. A num-
ber of cassette-like cryptic exons could be not be spliced
in silico to any annotated coding exons, suggesting a role
for cryptic exon inclusion in to upstream open reading
frames and 3′ untranslated regions, both of which have
been observed to provide a site for modulation of gene
expression by introducing premature termination co-
dons [61, 62].
Consistent with this possibility, a recent proteomic
study of TDP-43 depletion in human SH-SY5Y cells [63]
that protein levels were changed for 3 of the 95 human
cryptic exon containing genes. Two, HUWE1 and
GOLGB1 had protein levels that were 8 and 31% of the
control cells respectively whereas the third, HNRNPH3
was found to be 7-fold increased under TDP-43 deple-
tion. Interestingly, the cryptic exon discovered in
HNRNPH3 falls upstream of the start codon whereas
those found in HUWE1 and GOLGB1 are predicted to
trigger NMD by inclusion into the coding sequence (see
Additional file 4: Table S1). Another gene with cryptic
splicing seen in both K562 datasets and in the initial
Ling HeLa data, AGRN, was recently shown to be de-
creased at the protein level in the cerebrospinal fluid of
ALS patients compared to healthy controls and other
neurological diseases [64]. Correct splicing of AGRN has
shown to be crucial for the formation of the neuromus-
cular junction [65].
Our current understanding of TDP-43’s role in cryptic
splicing is that of a safeguard against the inclusion of po-
tentially damaging intronic sequence into transcripts.
However, the relationship between the UG-rich se-
quences and the strong 5′ and 3′ splice sites and their
changes over evolutionary time are unknown as we ob-
served no conserved cryptic exons between human and
mouse.
Using publicly available ENCODE eCLIP data, we
identified a number of RNA binding proteins that also
bind subsets of human cryptic exons under normal con-
ditions, that is, in the presence of TDP-43. It is
unsurprising that the splicing factors U2AF35 and
U2AF65 are enriched as they preferably bind
pyrimidine-rich 3′ splice site sequences, which all cryp-
tic exons appear to possess. That only 10–15% of cryptic
exons show U2AF35/65 binding may be due to competi-
tion from TDP-43 in a manner similar to that seen be-
tween hnRNP C and U2AF65. TIA-1 is an exciting
finding due to its role in the formation of stress gran-
ules, key regulators of RNA stability [66]. In addition,
IGF2BP1 has been reported as binding to TDP-43 in
HEK293T and HeLa cell extracts [57, 58], whereas
SRSF7 was reported as binding to TDP-43 in mouse
N2A cells [56]. None of the observed proteins have been
reported to change their protein level in response to
TDP-43 depletion [63].
As the majority of cryptic exons are predicted to lead
to nonsense-mediated decay of the inclusion transcript it
seems peculiar that we can observe these transcripts at
all. We hypothesise that cryptic splicing may be much
more widespread than can be observed by RNA sequen-
cing due to the highly efficient nature of nonsense-
mediated decay. Over half of all cryptic exon genes are
significantly downregulated in each dataset (Fig. 2b),
suggesting that cryptic exon inclusion may be a key
mechanism in the widespread changes in RNA expres-
sion that occur upon TDP-43 depletion. An alternative
hypothesis is there is an interaction between TDP-43
and hnRNPC with the NMD machinery, which reduces
the efficiency of degradation that is not shared by FUS.
Experiments depleting both hnRNP C and the NMD
component UPF1 have increased the number of hnRNP
C-associated cryptic exons even further [67], suggesting
that these experiment should be repeated for TDP-43
and FUS to better understand the relationship between
cryptic splicing and mRNA degradation. Differences be-
tween the number of cryptic exons between TDP-43 and
hnRNP C depletion may also relate to this, as well as dif-
ferences in strength of depletion. Both TDP-43 and FUS
proteins are known to bind their own mRNAs [68, 69]
and so may compensate protein levels in response to
shRNA knockdown.
Two genes, ATG4B and GPSM2, have previously been
demonstrated to have cryptic exon inclusion RNA tran-
scripts in ALS patient brain samples, suggesting a role
for cryptic splicing in disease [25]. Our analysis also
identified a cryptic exon in ATG4B in human cells, but
not GPSM2; however we did not analyse human brain
data. By expanding the list of cryptic exons, it will be
(See figure on previous page.)
Fig. 7 Mining of ENCODE eCLIP data in K562 and HepG2 cells. a RNA-binding proteins (RBPs) with significant (P < 0.05) proportion of overlapping
cryptic exons (red) compared to sampled intronic sequence from the same (green) and adjacent introns (blue). b Comparison of eCLIP datasets
from different RNA binding proteins (columns) showing the overlap with the cryptic exons (rows). RBPs in bold typeface are from K562 cells
whereas those in regular typeface are from HepG2 cells
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interesting to explore whether these are also dysregu-
lated in ALS patient brains. However, such analysis may
prove challenging owing to the likely small concentra-
tions of RNA originating from diseased cells in brain
homogenate and the likelihood of degradation by NMD.
Alternate strategies may involve mass spectrometry
screens for the subset of cryptic exon containing genes
that escape the NMD process and are translated into
functional or truncated proteins. Such proteins may rep-
resent useful biomarkers for TDP-43 mislocalization and
therefore ALS pathology.
A recent paper has used a complementary bioinfor-
matic method to increase the number of cryptic exons
seen in the Ling data [70]. This study extends the cryptic
splicing phenomenon to RBM17, another RNA-binding
protein. This finding makes the very low number of
cryptic exons observed in the FUS depletion datasets
even more surprising,
Conclusions
We confirm the presence of cryptic exons after TDP-43
depletion and show they have a negative impact on the
genes they reside in, leading to decreased expression
levels. Further work is warranted to determine the rele-
vance of cryptic exons to ALS and FTD pathogenesis.
Additional files
Additional file 1: Figure S1. Pre-classification output of CryptEx pipeline
demonstrates a variety of novel splicing events in TDP-43, FUS and hnRNP C
depletion data. Every novel splicing event plotted by mean depth of reads
covering the novel event against log2(fold change) between depletion and
control samples. The cryptic exon classifier throws out any splicing event
where the canonical intron in which the cryptic splicing event appears is
represented by less than five spliced reads (purple) or where the |log2(fold
change)| < 0.6 (light blue). Splicing events are classified as cryptic exons if
the spliced reads agree with the rest of the reads and have at least 1 spliced
read per sample (red). Those that fail this step are coloured orange.
(ZIP 1386 kb)
Additional file 2: Figure S2. Each cryptic exon discovered in either of
the two mouse datasets. For each dataset, the biological replicates were
combined to create merged BAM files for each condition. The BAM files
were loaded into IGV for visualisation. Read coverage and splice junctions
are shown. The Ensembl transcripts for the mm10 build are provided, as
are the coordinates of the cryptic exons discovered by CryptEx.
(PDF 2436 kb)
Additional file 3: Figure S3. Each cryptic exon discovered in either of
the two human K562 datasets. As above, with the hg38 human genome
build. (PDF 5917 kb)
Additional file 4: Tables S1 and S2. Quantification of all results for
each cryptic exon discovered by CryptEx in mouse (ST1) and human
(ST2). Change in percent spliced in (ΔPSI) scores were calculated by
taking the difference of ratios of novel splice junctions over the sum of
novel and annotated (intron-spanning) splice junctions in control and
depletion samples for the 5′ and 3′ splice junctions. (ZIP 8 kb)
Additional file 5: Tables S5 and S6. Inclusion of cryptic exons in normal
mouse (ST5) and human (ST6) tissues. RNA-seq data from multiple mouse
tissues from [52] and multiple human tissues from the GTEx project [53] was
downloaded from the Sequence Read Archive (accession PRJNA177791) and
dbGap (phs000424.v6.p1) respectively. All samples were aligned with STAR
using two-pass mapping. The resulting junction coordinates were grouped
into overlapping clusters for each tissue using Leafcutter [31]. A custom R
script then queried the resulting junction tables for evidence of junctions
belonging to the previously discovered mouse and human cryptic exons, as
well as the canonical junctions in which the cryptic exons splice to and from.
The counts of upstream and downstream junctions in each sample were
divided by the counts of the canonical junction to produce an inclusion ratio.
For each cryptic exon that was detected, the mean inclusion ratio for each
tissue is presented with the standard deviation. For the 52 mouse cryptic
exons, only 4 showed any evidence of being included in normal tissues. Reep3
E001i1 and Adipor2 E010i2 are included in a few tissues at very low levels.
Elmod1 E003i2 is seen in brain tissue at an inclusion rate above 10%, whereas
Thoc7 E007i1 was included in every tissue bar heart. However, the inclusion
rates were highly variable. Among the 95 human cryptic exons, only three
were detected in 49 different human tissues from the GTEx project. MPDZ
E015i1, UHRF2 E017i2 and DEAF1 E005i2 were all detected in at least 1 tissue.
Only UHRF2 E017i2 was regularly seen above 10% inclusion, albeit with very
high variance between samples. (PDF 66 kb)
Additional file 6: Figure S4. Motif finding with HOMER The top ten
motifs reported by the algorithm when comparing flanked cryptic exons
with adjacent intronic sequence. The red asterisk indicates that the motif
is potentially a false positive result. (TIF 1799 kb)
Additional file 7: Tables S3 and S4. All repeat elements enriched in
mouse (ST3) and human (ST4) cryptic exons. For each class of repeat
element that was enriched in a set of cryptic exons, the exact
overlapping repeat element was compiled into a table. The strand
column refers to the orientation of the gene, not the repeat element. For
the simple repeats, all annotations are made in the positive direction.
Therefore (AC)n containing repeats in the antisense direction are in fact
(GT)n repeats for genes on the negative strand. Figure S5. The RNA
sequence of the B2 SINE in the antisense orientation. The DNA sequence
of the B2 SINE was downloaded from lncrnadb [71] and converted to the
reverse complement to get its antisense orientation. Ts were changed to
Us to reflect the RNA sequence. Stretches of UG and GU are highlighted
in red. (PDF 123 kb)
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